Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

BiOasis Technologies Inc V.BTI

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  BIOAF

biOasis Technologies Inc is a biopharmaceutical company focused on the delivery of therapeutics across the blood-brain barrier and into the brain tissue. Its focus is to address unmet medical needs with its proprietary Transcend Platform.
Price: $1.07 | Change: $-0.02 | %Change: -1.83%
Volume: 95,012 | Day High/Low: 1.07/1.04 | 52 Week High/Low: 1.35/0.67
View modes: 
0 stars

Winter Solstice

The days will get lighter as we move toward spring and summer. So too, will the burden of holding BTI for some. Much brighter days ahead for all. Merry Christmas to all..........and here's to an...read more
0 stars

BTI December House Positions

House Positions for C:BTI from 20141201 to 20141219 House Bought $Val Ave Sold $Val Ave Net $Net...read more
1 star

RE:RE:hey oilpatch,

you are a funny guy LOP.... (and not a scumbag)  Merry Christmas to all of you.  rate and reply
1 star

RE:hey oilpatch,

Anyways guys....merry christmas to all you guys...im sorry for being a scum on here for soblong...just was worried is all....i ll try to be not a scumbag in the new year...when our accounts are filled...read more
3 stars

hey oilpatch,

any messages? drj  rate and reply
0 stars

RE:RE:RE:RE:Roche

I hear ya, Noobski, but I used "would be" because Transcend needs some more success, and it wouldn't be anything positive for Roche unless they acquired it. So there is still a lot of "would be" in...read more
0 stars

RE:RE:RE:RE:Roche

j.d the way you write is almost as though you've written books?....not sure just the style seems like that....I just wish I could spell half as good....then id be getting somewhere  rate and reply
0 stars

RE:RE:RE:Roche

One adjustment JD, your second paragraph; I think it sounds better if you replace “would be” with “is”  rate and reply
0 stars

BTI Level 2 - 3pm ET

Level 2 Quote Market Maker Shares Bid Price Ask Price Shares Market Maker     9,700 1.070 1.090 21,600     46,400 1.050 1.100 13,000     6,200 1.040 1.110 3,000...read more
4 stars

RE:RE:Roche

The cancers wars continue. Kadcyla (TDM-1) has failed to show increased efficacy. Roche cannot mitigate its loss of patent protection for Herceptin. The big thing about a biOasis Transcend peptide...read more
0 stars

RE:RE:Seeking Alpha

me thinks we're going for a major joy ride very soon!   drj!  rate and reply
0 stars

RE:RE:Roche

I dont understand ....it would be so cheap at this poi t for someone to take a stab at us to possibly advance their therPies to the brain. .....so cheap....and yest we never hear of an offer or a...read more
0 stars

RE:Seeking Alpha

She also discussed BTI in another blog post in July.  Kevetrin The Salt That Is Worth Gold! Jul 16, 2014 2:28 PM About 1/3 the way down in a paragraph starting with "For approximately a year, Roche...read more
0 stars

RE:Roche

i wouldn't be surprised that roche, like others, have had trouble with percentage of injected dose being ablel to cross bbb to show efficacy.   maybe they want to take a closer look at our peptide...read more
1 star

RE:Roche

Perhaps Roche will be looking for a way to distinguish Herceptin from the Biosimilars? --------------------------------- Roche's bid to sub Kadcyla for Herceptin takes a big hit with lackluster...read more
1 star

Roche

Double blow for Roche as breast cancer, Alzheimer's studies fail Fri Dec 19, 2014 12:52pm GMT By Silke Koltrowitz and Ben Hirschler ZURICH/LONDON, Dec 19 (Reuters) - Roche suffered a double blow on...read more
0 stars

RE:RE:Seeking Alpha

You just soumded like smeagull from lord of the rings lol doc  rate and reply
5 stars

RE:Seeking Alpha

2 very important statements in there. 1) Bioasis has failed to define a pathway to and through the US, and or Canadian FDA without having a major partner. 2) I believe that both Cellceutix and Bioasis...read more
0 stars

RE:Seeking Alpha

Thanks for sharing.  rate and reply
0 stars

Seeking Alpha

Interesting read! http://seekingalpha.com/instablog/21116141-ellaruth/3428735-bioasis-positioned-to-be-swallowed-by-astrazenecas-medimmune  rate and reply